Navigation Links
Alexza Reports Preliminary 2013 Second Quarter Financial Results
Date:8/8/2013

MOUNTAIN VIEW, Calif., Aug. 8, 2013 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported preliminary financial results for the quarter ended June 30, 2013.  The preliminary net loss for the quarter ended June 30, 2013, was $3.4 million compared to $7.0 million during the same quarter in 2012.  The preliminary net loss for the six months ended June 30, 2013 and 2012, was $24.1 million and $10.8 million, respectively.  At June 30, 2013, Alexza had consolidated cash, cash equivalents and marketable securities of $35.0 million.

"Alexza continues to mark steady progress against our objectives to commercialize ADASUVE® and advance our Staccato® pipeline candidates," said Thomas B. King, President and CEO of Alexza.  "In the second quarter, we entered into an exclusive agreement with Teva to market ADASUVE in the U.S.  We believe Teva is an ideal partner for ADASUVE, and we are impressed by their capabilities, commitment and enthusiasm." 

King continued, "Most recently, our partner Ferrer initiated sales of ADASUVE in the European Union, with the first product sale in Germany.  In addition, we are preparing to advance AZ-002 (Staccato alprazolam) for acute repetitive seizures into Phase 2 clinical studies by year-end."

Alexza Business Updates

  • In May 2013, Alexza entered into an exclusive U.S. license and supply agreement for ADASUVE with Teva Pharmaceuticals USA, Inc.  Teva is responsible for all U.S. development and commercialization activities for ADASUVE, including U.S. post-approval clinical studies.  Alexza is responsible for manufacturing and supplying ADASUVE to Teva for commercial sales and clinical trials.
    Alexza received an upfront cash payment of $40 million, $1
    '/>"/>

  • SOURCE Alexza Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Alexza Pharmaceuticals to Present at the 2013 Wedbush Life Sciences Management Access Conference
    2. Alexza Reports 2013 First Quarter Financial Results
    3. Alexza Pharmaceuticals to Present at Antiepileptic Drug and Device Trials (AED) XII Conference Highlighting Advances in the Treatment of Epilepsy
    4. Alexza to Report 2013 First Quarter Financial Results on Thursday, May 9, 2013
    5. Alexza Reports 2012 Fourth Quarter and Full Year Financial Results
    6. Peter W. Schineller Joins Alexza Pharmaceuticals as Senior Vice President and Chief Commercial Officer
    7. Alexza to Report 2012 Year-End Financial Results on Tuesday, March 26, 2013
    8. Alexza Pharmaceuticals Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
    9. Alexza Pharmaceuticals to Present at the Stifel Nicolaus 2012 Healthcare Conference
    10. Alexza Reports 2012 Second Quarter Financial Results and Provides Business Update
    11. Alexza Announces Management Promotions
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/17/2014)... NEW YORK , Sept. 17, 2014 /PRNewswire/ ... Summary GlobalData,s new report, "Germany ... market data on the Germany Gynecological Devices market. ... dollars, volume (in units) and average prices (in ... Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization ...
    (Date:9/17/2014)... , Sept. 17, 2014  Dr. Stephen Loyd ... White House today for National Recovery Month, stars in ... advocates released today. Consumer advocates were also joined by ... spoke out after losing her fiancée because of a ... doctor had a history of crack cocaine abuse. Proposition ...
    (Date:9/17/2014)... Mass. , Sept. 17, 2014 /PRNewswire/ ... disease/ulcerative colitis (CD/UC) patients eligible for biologic ... receive a biologic. Surveyed gastroenterologists cite patients, ... reason for low penetration rates, followed by ... and UC patients receiving biologics, Janssen Biotech,s ...
    Breaking Medicine Technology:Germany Gynecological Devices Market Outlook to 2020 2Germany Gynecological Devices Market Outlook to 2020 3Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 2Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 3The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 2The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 3
    (Date:9/18/2014)... Dr. Suzaunna Clark, Psychologist, Life Coach ... beauty has to be seen to be believed and ... order to be used. Together, both lead to hearts ... how to do both. , Dr. Clark ... Healing Hearts system, which provides professional guidance on dealing ...
    (Date:9/18/2014)... The Nautilus/ASG relationship is perfectly suited ... and even long term data archiving, to verticals that ... time. This includes media and entertainment, life sciences and ... Nautilus and ASG-Digital Archive will drive down the cost ... is pleased to work with ASG to expand its ...
    (Date:9/17/2014)... Recently, UWDress.com, an innovative company that ... occasion outfits, has released its 2014 empire waist ... has launched a big sale for these new and ... deeply discounted rates, from 15 to 65 percent off. ... on using comfortable to wear materials. Its elegant items ...
    (Date:9/17/2014)... Charlotte, NC (PRWEB) September 18, 2014 ... , U.S. emergency departments treat an estimated 173,285 sports- ... and adolescents every year. Soon, a blood test may ... concussion is and how long recovery will take. ... reported that they have found a way to ...
    (Date:9/17/2014)... CA (PRWEB) September 17, 2014 ... & Drug Administration report titled “Adverse Events Associated ... as a Dermal Filler,” unapproved use of Expression, ... has resulted in adverse reactions including discoloration, lumps, ... products with FDA approval for cosmetic use include ...
    Breaking Medicine News(10 mins):Health News:Suzaunna-Where Life! Happens Announces the Launch of Healing Hearts 2Health News:Suzaunna-Where Life! Happens Announces the Launch of Healing Hearts 3Health News:storageFOUNDRY and ASG Software Solutions Partner to Integrate ASG-Digital Archive with the Nautilus Software-Defined Storage Platform 2Health News:storageFOUNDRY and ASG Software Solutions Partner to Integrate ASG-Digital Archive with the Nautilus Software-Defined Storage Platform 3Health News:2014 Empire Waist Evening Dress Collection Now Unveiled At UWDress.com 2Health News:Breakthrough blood test will improve concussion diagnoses, treatment 2Health News:Breakthrough blood test will improve concussion diagnoses, treatment 3Health News:Simon Ourian, Kim Kardashian's Cosmetic Surgeon, Warns About Illegal Use of Expression as a Dermal Filler 2
    ... New research from the University of New Hampshire shows that ... are more likely to move on to harder illicit drugs as ... pot will use other illicit drugs as young adults has more ... according to the new research. In fact, the strongest predictor of ...
    ... Wyss Institute for Biologically Inspired Engineering at Harvard and ... in one of the most microscopic forms of lifebacteria. ... Nature . In studying the development of ... populations most adept at withstanding doses of antibiotics are ...
    ... 1, 2010 Very low birthweight and very preterm infants are ... hospitals with neonatal intensive care units specially equipped to care ... at those specialized facilities. "We encourage women who have ... about the care their baby may need after birth and ...
    ... By Amanda Gardner HealthDay Reporter , WEDNESDAY, ... treat high blood sugar in type 2 diabetics may hold ... to extremely preliminary findings in a mouse study. In ... report that metformin was associated with a substantial reduction (up ...
    ... needed to address breast cancer in Mexican-origin women in ... of Texas MD Anderson Cancer Center, which was published ... Among the Mexican-origin women with breast cancer who were ... than the national average for non-Hispanic white women. This ...
    ... University of Illinois scientists will learn whether protein supplements ... cardiovascular disease and retain physical function, thanks to a ... (NIH). "Patients with kidney failure face many health ... common forms of heart disease, and they also develop ...
    Cached Medicine News:Health News:Risk of marijuana's 'gateway effect' overblown, new UNH research shows 2Health News:New research finds evidence of charitable behavior in bacteria 2Health News:Neonatal intensive care units critical to infant survival 2Health News:Diabetes Drug Metformin Linked to Lower Lung Cancer Rate in Mice 2Health News:Diabetes Drug Metformin Linked to Lower Lung Cancer Rate in Mice 3Health News:Targeted strategies needed to find, prevent and treat breast cancer among Mexican-origin women 2Health News:Targeted strategies needed to find, prevent and treat breast cancer among Mexican-origin women 3Health News:Will extra protein and exercise help dialysis patients? U of I profs get $2.1 million to find out 2Health News:Will extra protein and exercise help dialysis patients? U of I profs get $2.1 million to find out 3
    Coude Foley Catheters (Latex) 2-Way Amber...
    Silicone Elastomer-Coated Latex Foley Catheters 3-Way...
    Silicone Foley Catheters 3-Way...
    Midstream Catch Kits...
    Medicine Products: